Past Events

More Filters
View Current Events
 Ticket Options
StudentsFree
 Location
FastForward
Baltimore, MD
February 13, February 13, ThursdayJoin Andrea Cox, M.D.-Ph.D. ’98, Director M.D.-Ph.D. Program and Professor of Medicine and Michael Kauffman, M.D.-Ph.D. '92, CEO, Karyopharm Therapeutics, Inc. to learn about Dr. Kauffman’s non-traditional career path, his experiences as a student and what led him to entrepreneurial success. Karyopharm focuses on the discovery, development and commercialization of first-in-class agents targeting nuclear transport for the treatment of cancer and other major diseases such as myelodysplastic syndrome, colorectal and prostate cancer, advanced solid malignancies or non-Hodgkin’s lymphoma.  This is a terrific opportunity for current M.D.-Ph.D. and Ph.D. students to gain career insights, network and learn from Dr. Kauffman’s experiences. Refreshments, light lunch and networking will follow the discussion.  Students are encouraged to prepare questions in advance.  About Dr. Kauffman Dr. Kauffman co-founded Karyopharm with Dr. Sharon Shacham in 2008 and has served as Chief Executive Officer since January 2011. Prior to joining Karyopharm, Dr. Kauffman served as Chief Medical Officer at Onyx Pharmaceuticals Inc. and as an operating partner at Bessemer Venture Partners where he led investments in biotechnology companies. In addition, he led the Velcade® (bortezomib) development program and the discovery and development of novel molecular diagnostics for major cancers including melanoma.  He currently serves on the board of directors and compensation committee of Verastem Inc., a publicly-traded biopharmaceutical company. Dr. Kauffman received his Bachelor of Arts in Biochemistry from Amherst College, his Doctor of Medicine and Doctor of Philosophy from Johns Hopkins Medical School, and trained in internal medicine and rheumatology at Beth Israel (now Beth Israel Deaconess Medical Center) and Massachusetts General Hospitals. He is board certified in internal medicine. Karyopharm focuses on nuclear medicine for the treatment of cancer and is the industry leader in oral SINE technology https://www.karyopharm.com/about/management-team/  medtalk-meet-ceo-and-co-founder-
    SOLD OUT
 Feb 13, 2020
 12:00 PM
Baltimore, MD: MedTalk: Meet Michael Kauffman, M.D., Ph.D. ’92, CEO and Co-Founder, Karyopharm Therapeutics, Inc.
 Location
This webinar will be streamed online
Baltimore, MD
February 13, February 13, ThursdaySponsored by Lifelong Learning Have you ever wondered why it is that people who desperately want to adopt healthier lifestyles don’t stick with them once their initial burst of motivation fades?  This provocative webinar will showcase a new science-based paradigm to better foster sustainable motivation and behavior change.  Dr. Michelle Segar will explain why logic-based reasons for behavior change (e.g., better heath, weight loss, disease prevention, etc.) keep people stuck in cycles of starting and stopping but not behavioral sustainability. Attendees will leave this session with a more strategic way to approach and promote the sustainable behavior necessary for achieving and sustaining improved health and well-being.  About the Speaker: Michelle Segar, PhD, MPH, MS bestselling author of No Sweat and sustainable behavior change scientist, directs the University of Michigan’s Sport, Health, and Activity Research and Policy Center. She has translated science into sustainable behavior change messages and programming for decades and is a recognized pioneer and leading authority in this field. Her comprehensive, science-based, and tailored approach to creating sustainable behavior change related to healthy lifestyles and well-being has made her a sought-after speaker, sustainable-behavior-change trainer, consultant, and learning/intervention expert for global organizations seeking to accelerate and sustain positive change. Register for this webinar and check out other online events here: https://alumlc.org/jhu/upcoming/event/MichelleSegarWebinar
 Feb 13, 2020
 12:00 PM
Lifelong Learning (Online) | Sustainable Change in Health, Fitness, and Well-being: Science-based Reasons to Harness the Right Why
 Ticket Options
Alumni & Guests$10
 Location
Johns Hopkins University School of Advanced International Studies
Washington, DC
February 11, February 11, TuesdaySponsored by Hopkins Alumni in Law The decriminalization and legalization of cannabis has been a high-speed train over the past eight years. Ms. Amy McDougal (Peabody '94) will be sharing her perspective as an attorney in the cannabis industry on the impact of legalization thus far, how legalization of cannabis impacts corporate operations and compliance, how the friction in federal and state law is unprecedented and both what we can learn from the dichotomy and how it may be resolved to increase patient access to medical marijuana. She will cover the legal landscape of medical marijuana currently, the projected changes in the months and years to come, the impact of the legalization of hemp, and how we can expect to see the marketplace morph due to the introduction of cannabis-based products.  MEET OUR SPEAKER Amy McDougal, Esq. (Peabody '94) Ms. McDougal is an attorney licensed in Virginia, DC, Georgia and Tennessee. She is certified by the Society of Corporate Compliance & Ethics as a Corporate Compliance and Ethics Professional (CCEP). In 2013, she founded CLEAResources LLC, a corporate resource for mitigation of legal and compliance risks. Ms. McDougal is also a Director of the International Association of Independent Corporate Monitors and the International Cannabis Bar Association. In addition to her position as director of the bar association, she chairs its active Ethics Committee. Previously, Ms. McDougal served as a Special Assistant United States Attorney and Air Force Judge Advocate General in the United States Air Force, where she served during both Operation Enduring Freedom and Operation Iraqi Freedom, attaining the rank of Major. She graduated from Johns Hopkins University Peabody Conservatory of Music with a Bachelor’s Degree in Flute Performance and received her Doctor of Jurisprudence from Vanderbilt Law School. washington-dc-the-changing-legal
 Feb 11, 2020
 06:30 PM
Washington, DC: The Changing Legal Landscape of Cannabis with Amy McDougal, Esq. (Peabody '94)
 Location
FastForward U Johns Hopkins Technology Ventures
Baltimore, MD
Affinity February 06, February 6, ThursdaySponsored by the Women of Hopkins Affinity At some point in time everyone will find they are faced with the challenge of a difficult conversation or situation. Maybe it’s giving feedback to a member of your team, or responding to a neighbor when they’ve put you in an uncomfortable position or taken you off guard. There are so many different thoughts and feelings that emerge when the phrase “difficult conversations” is uttered, and what’s difficult and uncomfortable is unique to each of us. No matter what your version might be, what matters most is how you choose to manage and respond to (or avoid) the situation. Alumni, student and friends will join our expert facilitators to learn how to strategically approach, reframe, and transform your “difficult” situations. You will also engage interactively with your fellow attendees to determine the tools you need to diffuse situations, resolve potential conflicts, and help you to achieve your end goals.  Refreshments will be served. Facilitators:               Stephanie Churchill '12  Stephanie D. Churchill is a 2012 graduate of the Johns Hopkins Carey Global MBA. While at Carey, she worked at the U.S. Department of State in the Office of the Under Secretary for Civilian Security, Democracy, and Global Affairs and was later promoted to Foreign Affairs Officer. Her area of expertise is human trafficking as a national and international security issue. She also holds an MA in Political Science and International Studies from the University of Delaware (2009) and a Certificate in International Studies from SAIS (2009). Currently, Stephanie is Vice President of Arbor Valley Tree Service in Baltimore, Maryland.             Eleni Pallas '95  Eleni is knee-deep into her second career after spending 20 years in global strategy and business development groups, primarily leading partnership and acquisition projects in the BRICs and emerging markets. A life-altering car accident in Siberia caught her by surprise when she realized that life can change from one day to the next and doing what she loved is better than doing what seemed safe. Since 2008, Eleni has been on a mission to equip leaders and change-makers with strategies that humanize the workplace. This means designing team cultures that create collaborative and innovative mindsets from which to respond ingeniously to market changes. Eleni has worked with leaders and teams in organizations such as UC Berkeley, Mercer, Whole Foods, SFSU, Ashoka and a wide variety of smaller social impact organizations. She has earned an MBA from George Washington University (with honors), a BS from the University of Maryland at College Park and coaching certification (PCC) from the International Coach Federation.2020-02-06 -- 6 -- 30 -- PM -- 2020-02-06 -- 8 -- 30 -- PM -- FastForwardU - Johns Hopkins Technology Ventures -- 320 West 29th Street, Suite 200 -- Baltimore -- MD -- 21211 -- USA -- 1 -- -- 0 -- Alumni and Guests -- 0 -- 0 Alumni and Guests 2020-02-06 -- 6 -- 30 -- PM -- 2020-02-06 -- 8 -- 30 -- PM -- FastForwardU - Johns Hopkins Technology Ventures -- 320 West 29th Street, Suite 200 -- Baltimore -- MD -- 21211 -- USA -- 1 -- -- 0 -- Current Students -- 0 -- 0 Current Students managing-difficult-conversations
 Feb 06, 2020
 06:30 PM
Managing Difficult Conversations: An Interactive Workshop Women of Hopkins Affinity
 Ticket Options
Alumni and Guests$25
 Location
HERE Arts Center
New York, NY
Affinity February 05, February 5, WednesdayJoin us for a new play by Edward Einhorn (Arts & Sciences '92) about his grandfather, Alexander S. Wiener, who discovered the Rh Factor in blood in 1937. The play is told through the lens of interviews with his mother, Jane Einhorn, a Ph.D. psychologist and visual artist who had recently experienced a stroke at the time of the interviews. The play uses a mixture of verbatim/found text and invented dialogue to examine Wiener's legacy, both scientific and familial. How does it change your life to have a world famous father...or grandfather? How does that legacy continue through the generations?  This will be the Untitled Theater Company No. 61's first production at HERE since The Marriage of Alice B. Toklas by Gertrude Stein in 2017, which received a Critic's Pick from Jesse Green at The New York Times. The performance will feature Alyssa Simon as Jane, who was described as "radiant," when she played Toklas in the earlier production.  Following the performance, we will gather for a talk with the playwright, Edward Einhorn, and Dr. Pablo Rubenstein, a former colleague of Alexander Wiener's who was involved in the early days of blood typing. They'll discuss Edward's grandfather and the science that came after the discovery. new-york-ny-drs-jane-and-alexand
 Feb 05, 2020
 07:00 PM
New York, NY: Drs. Jane and Alexander - A Play by Edward Einhorn (Arts and Sciences 92)